Hawaii Pacific Health
11
2
3
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
9.1%
1 terminated/withdrawn out of 11 trials
85.7%
-0.8% vs industry average
0%
0 trials in Phase 3/4
33%
2 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (11)
Comparing a Team-Based Approach to Standard Well-Child Visits To Improve Preventive Care Services
Role: collaborator
Tension Versus no Tension With Foley Bulb Induction
Role: lead
Doxycycline Treatment to Prevent Progressive Coronary Artery Dilation in Children With Kawasaki Disease
Role: lead
Pediatric Physical Activity for Children With Cancer
Role: collaborator
Transcutaneous Electrical Nerve Stimulation for Post-Cesarean Pain Control
Role: lead
The Effect of Pharmaceutical Grade L-glutamine (Endari) on Glycemic Control in Patients With Diabetes Mellitus Type II
Role: lead
Ferumoxytol-enhanced Imaging and Mapping in neuroAIDS
Role: collaborator
Investigator Sponsored Trial of Polypoidal Choroidal Vasculopathy (PCV) Evaluation Assessing High-Dose Ranibizumab Prospectively (PEARL2)
Role: lead
The Use of Heliox Via Nasal CPAP to Prevent Early CPAP Failure in Premature Infants: A Feasibility Study
Role: lead
Managing Diabetes in Pregnancy Using Cell Phone/Internet Technology
Role: lead
Ranibizumab for Polypoidal Choroidal Vasculopathy (PCV)
Role: lead
All 11 trials loaded